Difference 12948000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $214.06M and net income of $9.90M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214.06M | $198.29M | $202.73M | $197.13M | $197.34M | $183.79M | $180.45M | $168.03M | $167.19M | $155.68M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $41.94M | $32.75M | $40.13M | $36.87M | $41.62M | $31.06M | $32.53M | $29.13M | $33.86M | $28.40M |
| Operating income | $21.95M | $12.48M | $16.77M | $25.33M | $24.94M | $19.64M | $19.65M | $12.85M | $15.57M | $14.93M |
| Net income | $9.90M | $5.04M | $4.15M | $13.14M | $12.39M | $9.90M | $9.24M | $6.63M | $7.51M | $8.05M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 15.07M | shares 15.17M | Unavailable | shares 15.20M | shares 15.20M | shares 15.13M | Unavailable | shares 15.08M | shares 15.07M | shares 15.02M |
| Pretax income | $19.05M | $10.56M | $14.96M | $22.88M | $22.65M | $17.33M | $18.32M | $12.34M | $14.80M | $14.76M |
| Income tax expense | $4.16M | $2.41M | $5.78M | $5.23M | $4.93M | $3.86M | $5.83M | $2.56M | $3.08M | $3.14M |
| Diluted EPS | $0.25 | $-0.12 | Unavailable | $0.48 | $0.58 | $0.80 | Unavailable | $0.39 | $0.47 | $0.46 |
| Selling, general & administrative | $19.00M | $18.27M | $18.12M | $17.41M | $17.48M | $16.24M | $15.57M | $14.38M | $14.25M | $14.08M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | $39.18M | $41.36M | $116.96M | $112.91M | $132.29M |
| Total assets | $1.25B | $1.24B | $1.20B | $1.20B | $1.18B | $1.18B | $1.17B | $1.03B | $1.02B | $1.02B |
| Current assets | $139.68M | $139.11M | $139.99M | $138.44M | $140.53M | $145.35M | $137.58M | $204.87M | $201.68M | $221.14M |
| Total liabilities | $482.22M | $459.19M | $433.81M | $413.83M | $414.01M | $420.68M | $408.42M | $358.47M | $353.16M | $345.29M |
| Current liabilities | $109.91M | $117.30M | $139.04M | $115.08M | $118.84M | $123.80M | $116.28M | $115.30M | $107.10M | $102.54M |
| Total equity incl. NCI | $449.17M | $469.43M | $476.89M | $504.78M | $502.29M | $498.96M | $490.02M | $484.12M | $485.62M | $481.23M |
| Temporary (mezzanine) equity | $317.49M | $313.44M | $293.31M | $277.66M | $263.30M | $260.05M | $269.02M | $186.60M | $184.35M | $190.73M |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $69.60M | $69.08M | $64.25M | $67.63M | $65.96M | $64.76M | $59.04M | $57.02M | $54.66M | $55.36M |
| Goodwill | $716.54M | $715.87M | $692.39M | $690.41M | $677.60M | $674.39M | $667.15M | $554.64M | $548.97M | $534.27M |
| Long-term debt | $215.46M | $194.04M | $152.59M | $151.46M | $151.91M | $157.24M | $142.53M | $132.92M | $135.70M | $136.75M |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $34.37M | $3.81M | $24.93M | $19.94M | $34.86M | -$4.68M | $19.41M | $22.12M | $28.99M | $4.42M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$6.41M | -$39.80M | -$5.44M | -$11.94M | -$12.71M | -$6.63M | -$94.85M | -$5.84M | -$28.29M | -$20.46M |
| Financing cash flow | -$31.52M | $28.86M | -$15.02M | -$10.99M | -$27.25M | $9.12M | -$153.00K | -$12.23M | -$20.08M | -$4.49M |
| Net change in cash | -$3.55M | -$7.13M | $4.47M | -$2.98M | -$5.10M | -$2.18M | -$75.60M | $4.05M | -$19.38M | -$20.54M |
| Stock-based compensation | $3.17M | $2.31M | $2.12M | $2.26M | $2.12M | $1.77M | $1.99M | $1.92M | $1.92M | $2.00M |
| Common dividends paid | Unavailable | Unavailable | $6.84M | $6.84M | Unavailable | Unavailable | $6.64M | $6.63M | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $5.62M | $6.00M | $4.64M | $5.50M | $5.74M | $5.87M | $5.53M | $4.16M | $4.30M | $4.10M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 19.6% | 16.5% | 19.8% | 18.7% | 21.1% | 16.9% | 18.0% | 17.3% | 20.3% | 18.2% |
| Operating margin | 10.3% | 6.3% | 8.3% | 12.8% | 12.6% | 10.7% | 10.9% | 7.6% | 9.3% | 9.6% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.5% | 1.2% | 1.0% | 1.1% | 1.1% | 1.0% | 1.1% | 1.1% | 1.1% | 1.3% |
| Current ratio | 1.27x | 1.19x | 1.01x | 1.20x | 1.18x | 1.17x | 1.18x | 1.78x | 1.88x | 2.16x |
| Revenue YoY growth | 8.5% | 7.9% | 12.3% | 17.3% | 18.0% | 18.1% | 16.6% | 12.0% | 10.4% | 4.8% |
| Net margin | 4.6% | 2.5% | 2.0% | 6.7% | 6.3% | 5.4% | 5.1% | 3.9% | 4.5% | 5.2% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.48x | Unavailable | 0.32x | 0.30x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.8% | 22.8% | 38.7% | 22.9% | 21.8% | 22.3% | 31.8% | 20.7% | 20.8% | 21.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.